Bin Xian Wei
Fortune : 1 M $ au 31/05/2026
Fortune : 1 M $ au 31/05/2026
Mr. Bin Xian Wei is an Independent Director at Palisade Bio, Inc. and a Vice President at Dar Sheng Trade & Technic Development Co. Ltd. He is on the Board of Directors at Palisade Bio, Inc. Mr. Wei was previously employed as an Independent Director by Seneca Biopharma, Inc. and a Manager-Business Development by Sakai Trading Co., Ltd. He received his undergraduate degree from Tianjin University, a graduate degree from Tianjin University and a graduate degree from Colorado School of Mines.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PALISADE BIO, INC. 0,37 % | 10/06/2026 | 613 355 ( 0,37 % ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PALISADE BIO, INC. | Directeur/Membre du Conseil | 01/01/2019 |
Dar Sheng Trade & Technic Development Co. Ltd. | Corporate Officer/Principal | 01/01/2015 |
| Sociétés | Poste | Fin |
|---|---|---|
| SAKAI TRADING CO., LTD. | Corporate Officer/Principal | 01/01/2010 |
| PALISADE BIO, INC. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Sakai Trading Co., Ltd.
Sakai Trading Co., Ltd. Wholesale DistributorsDistribution Services Exports, imports and manufactures chemicals, synthetic resin & electronic materials | Distribution Services |
Tianjin University
Tianjin University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Colorado School of Mines
Colorado School of Mines Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seneca Biopharma, Inc.
Seneca Biopharma, Inc. BiotechnologyHealth Technology Manufactures biotherapeutic products | Health Technology |
Dar Sheng Trade & Technic Development Co. Ltd. | |
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national